The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Micafungin
Micafungin · MICAFUNGIN SODIUM 10 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Zydus Lifesciences Limited
NDC 70771-1683-01 · 1 VIAL in 1 CARTON / 5 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $396.29 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215241
- TE code
- AP
- Approval date
- Oct 24, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Micafungin (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Biocon Pharma Inc. | MICAFUNGIN SODIUM 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Biocon Pharma Inc. | MICAFUNGIN SODIUM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | MICAFUNGIN 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | MICAFUNGIN 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd | MICAFUNGIN 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd | MICAFUNGIN 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | MICAFUNGIN SODIUM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | MICAFUNGIN SODIUM 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | MICAFUNGIN SODIUM 20 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | MICAFUNGIN SODIUM 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | MICAFUNGIN SODIUM 20 mg/mL | Jul 15, 2026 | Aug 26, 2026 |
| Par Health USA, LLC | MICAFUNGIN SODIUM 10 mg/mL | Jul 15, 2026 | Aug 26, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Micafungin — NDC 70771-1683-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70771168301.
Free to cite with attribution — see how the data is put together.